1. Zhuang, Ming, Zhang, Xue, Li, L U, Wen, Liming, Qin, Jiamin. 2024. Tmem39b promotes tumor progression and sorafenib resistance by inhibiting ferroptosis in hepatocellular carcinoma. In Oncology research, 32, 1347-1357. doi:10.32604/or.2024.046170. https://pubmed.ncbi.nlm.nih.gov/39055886/
2. Kim, Seok Jin, Sohn, Insuk, Do, In-Gu, Paik, Soonmyung, Kim, Won Seog. 2013. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay. In Annals of hematology, 93, 437-47. doi:10.1007/s00277-013-1884-0. https://pubmed.ncbi.nlm.nih.gov/23975159/
3. Du, Yuehui, Zeng, Xiaohui, Yu, Weiwei, Xie, Wei. 2022. A transmembrane protein family gene signature for overall survival prediction in osteosarcoma. In Frontiers in genetics, 13, 937300. doi:10.3389/fgene.2022.937300. https://pubmed.ncbi.nlm.nih.gov/35991561/
4. Liu, Renyan, Long, Yong, Liu, Ran, Yan, Huawei, Cui, Zongbin. 2022. Understanding the Function and Mechanism of Zebrafish Tmem39b in Regulating Cold Resistance. In International journal of molecular sciences, 23, . doi:10.3390/ijms231911442. https://pubmed.ncbi.nlm.nih.gov/36232766/
5. Berger, Amund Holte, Bratland, Eirik, Sjøgren, Thea, Oftedal, Bergithe Eikeland, Wolff, Anette Susanne Bøe. 2021. Transcriptional Changes in Regulatory T Cells From Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing. In Frontiers in immunology, 12, 722860. doi:10.3389/fimmu.2021.722860. https://pubmed.ncbi.nlm.nih.gov/34526996/
智鼠故事 
